Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

12:09, 23 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (Created page with "{{Publication |Title=L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial |Topic=Carnitine |Author=Kraft, M; Kraft, K; Gärtner, S; Mayerle, J; Simon, P; Weber, E; Schütte, K; Stieler, J; Koula-Jenik, H; Holzhauer, P; Gröber, U; Engel, G; Müller, C; Feng, YS; Aghdassi, A; Nitsche, C; Malfertheiner, P; Patrzyk, M; Kohlmann, T; Lerch, MM |Year=2012 |Journal=Deutsche Zeitschrift für Onkologie |DOI=http://www.nutritionj.com/...")
09:30, 23 July 2024 JDoerfler talk contribs created page Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Reference |Reference=Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients }} {{Study Note}} =Brief summary= The study investigated the influence of carnitine on the inflammatory and insulin response in patients following surgery for gastric or colorectal cancer. Eight patients were randomly assigned to the control group, who received the usual...")
09:27, 23 July 2024 JDoerfler talk contribs created page Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Publication |Title=Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients |Topic=Carnitine |Author=Koyama Y; Moro K; Nakano M; Miura K; Nagahashi M; Kosugi S-i; Tsuchida J; Ikarashi M; Nakajima M; Ichikawa H; Hanyu T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Wakai T |Year=2017 |Journal=Journal of clinical medicine research |DOI=https://doi.org/10.14740/j...")
12:25, 22 July 2024 JDoerfler talk contribs created page Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Reference |Reference=Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy }} {{Study Note}} =Brief summary= This large-scale study, initially involving 409 breast cancer patients, focused primarily on the effect of carnitine on peripheral neuropathy (an increased toxicity in the brain that negatively affects all functions of the body) caused...")
12:12, 22 July 2024 JDoerfler talk contribs created page Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Publication |Title=Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy |Topic=Carnitine |Author=Hershman, DL; Unger, JM; Crew, KD; Minasian, LM; Awad, D; Moinpour, CM; Hansen, L; Lew, DL; Greenlee, H; Fehrenbacher, L; Wade, JL; Wong, SF; Hortobagyi, GN; Meyskens, FL; Albain, KS |Year=2013 |Journal=Journal of clinical oncology: official journal of the Am...")
08:51, 22 July 2024 JDoerfler talk contribs created page Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial }} {{Study Note}} =Brief summary= 376 patients with different types of cancer took part in this study to investigate carnitine on tiredness/fatigue caused by cancer or the associated chemotherapy and medication. They were randomly assigned to 2 groups, one...")
08:46, 22 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Publication |Title=L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial |Topic=Carnitine |Author=Cruciani, RA; Zhang, JJ; Manola, J; Cella, D; Ansari, B; Fisch, MJ |Year=2012 |Journal=Journal of clinical oncology: official journal of the American Society of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2011.40.2180 |Authors Abstract=Pur...")
14:18, 16 July 2024 JDoerfler talk contribs created page Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study }} {{Study Note}} =Brief summary= The study investigated the impact of carnitine on fatigue/exhaustion caused by cancer and the associated chemotherapy and medication. A total of 33 patients with various cancers and a carnitine deficiency caused by the treatment were randomly assigned to two groups. One group...")
13:38, 16 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Publication |Title=L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study |Topic=Carnitine |Author=Cruciani, RA; Dvorkin, ED; Homel, P; Culliney, B; Malamud, S; Lapin, J; Portenoy, RK; Esteban-Cruciani, N |Year=2009 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2008.03.021 |Authors Abstract=Carnitine deficiency is prevalent in populations with chronic i...")
11:57, 16 July 2024 JDoerfler talk contribs created page Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Reference |Reference=Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy }} {{Study Note}} =Brief summary= This study investigated the effect of carnitine as an adjuvant to the usual medication (sildenafil) in erectile dysfunction following prostatectomy. Ninety-six patients participated in the study, of which 29 were in the control...")
10:00, 16 July 2024 JDoerfler talk contribs created page Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Publication |Title=Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy |Topic=Carnitine |Author=Cavallini, G; Modenini, F; Vitali, G; Koverech, A |Year=2005 |Journal=Urology |DOI=https://doi.org/10.1016/j.urology.2005.05.014 |Authors Abstract=Objectives To determine whether propionyl-l-carnitine (PLC) plus acetyl-l-carnitine (ALC) improves the e...")
09:12, 16 July 2024 JDoerfler talk contribs created page Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Reference |Reference=Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients }} {{Study Note}} =Brief summary= =Study Design= In this study, breast cancer patients were examined during radiotherapy, with one half taking curcumin alongside radiotherapy and the other half taking a placebo. In the curcumin group, the severity of radiodermatitis (a common skin disease associated with ra...")
07:22, 16 July 2024 JDoerfler talk contribs created page Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Publication |Title=Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients |Topic=Curcumin |Author=Ryan, JL; Heckler, CE; Ling, M; Katz, A; Williams, JP; Pentland, AP; Morrow, GR |Year=2013 |Journal=Journal of Radiation Research |DOI=https://doi.org/10.1667/RR3255.1 |Authors Abstract=Radiation dermatitis occurs in approximately 95% of patients receiving radiotherapy (RT) for breast cancer. We con...")
14:18, 15 July 2024 JDoerfler talk contribs created page Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Reference |Reference=Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study }} {{Study Note}} =Brief summary= This study investigated the efficacy of a curcumin mouth rinse compared to a povidone-iodine mouth rinse in patients with head and neck cancer during radiotherapy. Throughout radiotherapy, mucositis (an inflammation of the mucosa, a common a...")
13:47, 15 July 2024 JDoerfler talk contribs created page Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Publication |Title=The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study |Topic=Curcumin |Author=Rao, S; Dinkar, C; Vaishnav, LK; Rao, P; Rai, MP; Fayad, R; Baliga, MS |Year=2014 |Journal=Integrative Cancer Therapies |DOI=https://doi.org/10.1177/1534735413503549 |Authors Abstract=Purpose. Radiation-induced oral mucositis is an acute morbidity seen in patients u...")
13:15, 15 July 2024 JDoerfler talk contribs created page Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Reference |Reference=Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were examined during radiotherapy. The patients were instructed to apply a gel to the entire oral cavity 3 times a day, with half receiving a curcumin gel and the other half a placebo gel. There were more cases of severe mucositis (an inf...")
13:09, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Publication |Title=The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer |Topic=Curcumin |Author=Mansourian, A; Amanlou, M; Shirazian, Sh; Moosavian Jahromi, Z; Amirian, A |Year=2015 |Journal=International Journal of Radiation Research |DOI=https://doi.org/10.7508/ijrr.2015.03.011 |Authors Abstract=Background: Different treatment and protective approaches for radiation-induced oral mucositis have been pract...")
12:30, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo cap...")
12:29, 15 July 2024 JDoerfler talk contribs created page Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Publication |Title=Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Hejazi, E; Ehtejab, G; Hara, N |Year=2016 |Journal=Nutrition and Cancer |DOI=https://doi.org/10.1080/01635581.2016.1115527 |Authors Abstract=Curcumin is an antioxidant agent with both radiosensitizing and radioprot...")
12:23, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Reference |Reference=Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo capsules instead. In the first study of XX, the quality...")
11:56, 15 July 2024 JDoerfler talk contribs created page Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Publication |Title=A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Ehtejab, G |Year=2013 |Journal=Journal of Cancer Science and Therapy |DOI=http://dx.doi.org/10.4172/1948-5956.1000223 |Authors Abstract=Background: Patients with prostate cancer who accede to radiation therapy usually experience several side effects and these toxicit...")
09:41, 15 July 2024 JDoerfler talk contribs created page Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Reference |Reference=Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study }} {{Study Note}} =Brief summary= Cisplatin is an effective chemotherapeutic agent. However, cisplatin is toxic to the outer hair cells of the ears and can cause hearing loss in patients receiving this therapy. In this study, the researchers tested the effect of Ginkgo biloba extract at a dose of 120 mg twice daily to prevent damage to...")
09:40, 15 July 2024 JDoerfler talk contribs created page Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Publication |Title=The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study |Topic=Ginkgo |Author=Dias, MA; Sampaio, ALL; Venosa, AR; Meneses, EA; Oliveira, CACP |Year=2015 |Journal=International Tinnitus Journal |DOI=https://doi.org/10.5935/0946-5448.20150003 |Authors Abstract=Objective: The purpose of this study was to evaluate, by using distortion product otoacoustic emission test, the action of Ginkgo biloba extract 761,...")
08:53, 15 July 2024 JDoerfler talk contribs created page Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Reference |Reference=Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 }} {{Study Note}} =Brief summary= Differentiated thyroid cancer (DTC) is a type of thyroid cancer that has developed in the cells of the thyroid gland that are responsible for the production of thyroid hormones. DTC is usually treated by removing the thyroid gland followed by radio...")
08:49, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Publication |Title=The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 |Topic=Ginkgo |Author=Dardano, A; Ballardin, M; Caraccio, N; Boni, G; Traino, C; Mariani, G; Ferdeghini, M; Barale, R; Monzani, F |Year=2012 |Journal=Thyroid |DOI=https://doi.org/10.1089/thy.2010.0398 |Authors Abstract=Background: Radioiodine (131I) therapy is usually performed in patients with d...")
08:27, 15 July 2024 JDoerfler talk contribs deleted page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors (content was: "{{Publication |Title=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial |Topic=Boswellia serrata |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors often suffer...")
09:15, 12 July 2024 JDoerfler talk contribs created page Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 (Created page with "{{Reference |Reference=Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer }} {{Study Note}} =Brief summary= Patients receiving chemotherapy often describe a decline in cognitive function (known as "chemo brain") that remains for months or years after chemotherapy has ended. As breast cancer survival rates improve, more attention is being paid to this side effect on...")
08:56, 12 July 2024 JDoerfler talk contribs created page Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer (Created page with "{{Publication |Title=The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer |Topic=Ginkgo |Author=Barton, DL; Burger, K; Novotny, PJ; Fitch, TR; Kohli, S; Soori, G; Wilwerding, MB; Sloan, JA; Kottschade, L.A; Rowland, KM; Dakhil, SR; Nikcevich, DA; Loprinzi, CL |Year=2013 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-012-1647-9 |Authors Abstract=Purpose Patient...")
07:39, 12 July 2024 JDoerfler talk contribs created page Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
07:37, 12 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Publication |Title=Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial |Topic=Vitamin E |Author=Villani, V; Zucchella, C; Cristalli, G; Galie, E; Bianco, F; Giannarelli, D; Carpano, S; Spriano, G; Pace, A |Year=2016 |Journal=Head and Neck |DOI=https://doi.org/10.1002/hed.24396 |Authors Abstract=Background. Few studies have investigated the effect of vitamin E in reducing the cisplatin (CDDP)-induced...")
08:12, 11 July 2024 JDoerfler talk contribs created page Upadhyaya et al. (2017): Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Reference |Reference=Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= In this study, the protective effect of vitamin E on radiotherapy-induced functional impairment of the salivary glands (auricular and submandibular salivary glands) in patients with thyroid cancer was investigated. The patients were divided into...")
08:01, 11 July 2024 JDoerfler talk contribs created page Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Publication |Title=Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial |Topic=Vitamin E |Author=Upadhyaya, A; Zhou, P; Meng, Z; Wang, P; Zhang, G; Jia, Q; Tan, J; Li, X; Hu, T; Liu, N; Wang, S; Liu, X; Wang, H; Zhang, C; Zhao, F; Yan, Z; Wang, X; Zhang, X; Zhang, W |Year=2017 |Journal=Nuclear Medicine Communications |DOI=https://doi.org/10.1097/MNM.0000000000000727 |Authors Abst...")
14:10, 9 July 2024 JDoerfler talk contribs created page Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Publication |Title=The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial |Topic=Vitamin E |Author=Shamsaei G; Ahmadzadeh A; Mehraban N |Year=2017 |Journal=Jundishapur Journal Of Natural Pharmaceutical Products |DOI=https://doi.org/10.5812/jjnpp.65027 |Authors Abstract=Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of proble...")
14:07, 9 July 2024 JDoerfler talk contribs created page Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Monocentric |Blinding=Single |Is randomized=Yes |Cross-over=No |Number of arms=2 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=70 |Analysis=ITT Analysis |Specifications on analyses=ITT not specified, but no drop-out reported. |Countries of data collectio...")
14:00, 9 July 2024 JDoerfler talk contribs created page Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial }} {{Study Note}} =Brief summary= This study investigated the efficacy of vitamin E in colorectal cancer patients to alleviate chemotherapy-associated peripheral neuropathy (i.e. damage to several peripheral nerves). The intervention arm took additional vitamin E during chemotherapy and the control arm received only a placebo. The...")
13:50, 9 July 2024 JDoerfler talk contribs created page Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Publication |Title=Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial |Topic=Vitamin E |Author=Salehi, Z; Roayaei M |Year=2015 |Journal=International Journal of preventive Medicine |DOI=https://doi.org/10.4103/2008-7802.169021 |Authors Abstract=Background: Peripheral neuropathy is one of the most important limitations of oxaliplatin base regimen, which is the standard for the treatment of colorectal cancer. Eviden...")
13:09, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2010): Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection for cisplatin neuropathy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instead. The results of this study are analogous to th...")
13:06, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Publication |Title=Vitamin E neuroprotection for cisplatin neuropathy |Topic=Vitamin E |Author=Pace, A; Giannarelli, D; Galie, E; Savarese, A; Carpano, S; Della Giulia, M; Pozzi, A; Silvani, A; Gaviani, P; Scaioli, V; Jandolo, B; Bove, L; Cognetti, F |Year=2010 |Journal=Neurology |DOI=https://doi.org/10.1212/WNL.0b013e3181d5279e |Authors Abstract=The clinical use of platinum-based antineoplastic agents is limited by severe peripheral neurotoxicity reported in up to 90%...")
12:06, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Reference |Reference=Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instea...")
12:02, 9 July 2024 JDoerfler talk contribs created page Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Publication |Title=Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy |Topic=Vitamin E |Author=Pace, A; Savarese, A; Picardo, M; Maresca, V; Pacetti, U; Del Monte, G; Biroccio, A; Leonetti, C; Jandolo, B; Cognetti, F; Bove, L |Year=2003 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2003.05.139 |Authors Abstract=Purpose: The aim of this study is to evaluate the neuroprotective effect of antioxidant...")
08:51, 9 July 2024 JDoerfler talk contribs deleted page TestPublication (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
08:49, 9 July 2024 JDoerfler talk contribs moved page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. to Dale, PS without leaving a redirect
08:27, 9 July 2024 JDoerfler talk contribs created page Test author (Created blank page)
07:26, 9 July 2024 JDoerfler talk contribs created page Mondal et al. (2014): Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Reference |Reference=Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy }} {{Study Note}} =Brief summary= In this study, four different arms of cancer patients were examined, all of whom received chemotherapy. During chemotherapy, one arm received additional vitamin E, one arm vitamin B12, one arm glutamine and the last arm carnitine. Components of peripheral neuro...")
07:22, 9 July 2024 JDoerfler talk contribs created page Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Publication |Title=Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy |Topic=Vitamin E, Carnitine, Vitamin B12 |Author=Mondal, S; Choudhury, KB; Sharma, S; Gupta, A; Dutta, S |Year=2014 |Journal=Clinical Cancer Investigation Journal |DOI=https://doi.org/10.4103/2278-0513.132113 |Authors Abstract=Context One of the major toxicities of paclitaxel is peripheral neuropathy, primar...")
06:28, 9 July 2024 JDoerfler talk contribs created page Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial }} {{Study Note}} =Brief summary= In this study, bladder cancer patients were examined with regard to the occurrence of recurrences after surgery, with half of the patients taking vitamin E daily and the other half taking nothing. There were significantly fewer recurrences in the vitamin E arm (19% vs. 36%) than in the control arm. There were no diff...")
06:27, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Publication |Title=Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial |Topic=Vitamin E |Author=Mazdak, H; Zia, H |Year=2012 |Journal=International Journal of Preventive Medicine |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278875/ |Authors Abstract=Background Most patients with superficial bladder cancer who undergo transurethral resection of bladder tumor show recurrence of the disease. Numerous studies have explored ways to...")
12:11, 8 July 2024 JDoerfler talk contribs created page Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Reference |Reference=Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial }} {{Study Note}} =Brief summary= This study investigated the effectiveness of vitamin E in preventing chemotherapy-induced peripheral polyneuropathy. The vitamin E arm took vitamin E twice a day in parallel with chemotherapy until one month after chemotherapy, while the control arm received only a place...")
11:46, 8 July 2024 JDoerfler talk contribs created page Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Publication |Title=The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial |Topic=Vitamin E |Author=Kottschade, LA; Sloan, JA; Mazurczak, MA; Johnson, DB; Murphy, BP; Rowland, KM; Smith, DA; Berg, AR; Stella, PJ; Loprinzi, CL |Year=2011 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-010-1018-3 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CIPN) co...")
13:50, 5 July 2024 JDoerfler talk contribs created page Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Reference |Reference=Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation }} {{Study Note}} =Brief summary= In this study, various leukemia patients were divided into two different arms prior to bone marrow transplantation. One arm began taking vitamin E seven days before the operation until 28 days afterwards in addition to chemotherapy, while the other received only a placebo in...")